Clinical Trials

Pfizer has reported new data from the Phase Ib clinical trial of PF-06939926 for the treatment of patients with Duchenne muscular dystrophy (DMD). PF-06939926 is an experimental, recombinant adeno-associated virus serotype 9 (AAV9) capsid with a shortened variant of the...

Biotechnology company Abivax has secured approval from France’s National Agency for the Safety of Medicines (ANSM) and French Ethics Committee (CPP) to conduct a Phase IIb/III clinical trial of ABX464 in Covid-19 patients. The miR-AGE trial will assess the drug...

Vibalogics, a global contract development and manufacturing organization (CDMO) that specializes in the production of virotherapy products, announced that it will manufacture additional clinical trial material for the lead COVID-19 vaccine candidate currently in development by the Janssen Pharmaceutical...

As the COVID-19 pandemic continues to limit movement all over the world, clinical trials have had to adapt by leveraging methodologies typically associated with hybrid or remote clinical trial designs. The alternative would be to suspend the trial and...

Humanigen, Inc., has dosed the first COVID-19 patient in its Phase III study for lenzilumab, its Humaneered anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody. Catalent provides clinical supply support to Humanigen and its partners from its Philadelphia facility. “We...

Bioclinica has introduced a specialized program for the adjudication of adverse events that could result from COVID-19 infection. Bioclinica's new program provides an out-of-the-box Clinical Endpoint Committee solution. This solution combines world-class medical expertise, an experienced adjudication management team,...

Catalent, a global leader in clinical supply services, welcomed the news by Humanigen, Inc., that it has dosed the first COVID-19 patient in its previously announced Phase 3 study for lenzilumab, the company’s proprietary Humaneered® anti-human granulocyte macrophage-colony stimulating...